• Publications
  • Influence
Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer.
TLDR
Radiation dose was shown to be the most significant prognostic factor for tumor control in stage I NSCLC treated using high-dose PBT and diameter was not significant for local control. Expand
Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
TLDR
Hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme was tolerable and beneficial if the target size was well considered and the possibility of controlling border region recurrences was pursued. Expand
Role of Radiotherapy for Local Control of Asymptomatic Adrenal Metastasis From Lung Cancer
TLDR
It is suggested that radiotherapy is a treatment option that can be used in addition to surgical resection and contribute to survival of patients with adrenal metastasis from lung cancer. Expand
Stereotactic Body Radiotherapy for Lung Tumors at the Pulmonary Hilum
TLDR
SBRT for lung tumors located in the pulmonary hilar region may be tolerable and acceptable, if multiple treatments to the same major bronchus are avoided, and irradiated volumes are carefully taken into consideration. Expand
Evaluation of liver function after proton beam therapy for hepatocellular carcinoma.
TLDR
It is indicated that liver function after PBT is significantly related to the percentage volume of normal liver that is not irradiated, which suggests that further study of the relationship between liver function and P BT is required. Expand
Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam.
TLDR
Proton beam therapy enabled a reduced irradiation dose to the optic chiasm and brainstem, enabling the safe treatment of unresectable carcinomas in the NCPS. Expand
Proton beam therapy interference with implanted cardiac pacemakers.
TLDR
PBT can result in pacemaker malfunctions that manifest as changes in pulse rate and pulse patterns, therefore, patients with cardiac pacemakers should be monitored by means of electrocardiogram during PBT. Expand
Long‐term follow‐up after proton beam therapy for pediatric tumors: a Japanese national survey
TLDR
The data indicate that PBT has the potential to reduce the risk of late mortality and secondary malignancy in cancer survivors and longer follow‐up is needed to confirm the benefits of PBT for pediatric tumors. Expand
Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.
TLDR
Repeated PBT was well tolerated and safe, even though the liver doses in many patients deviated substantially from well-known critical levels for RILD. Expand
Hyperfractionated concomitant boost proton beam therapy for esophageal carcinoma.
TLDR
The results suggest that hyperfractionated PBT is safe and effective for patients with esophageal cancer. Expand
...
1
2
3
4
5
...